TPIV will soar with positive Phase 1 results. Stock price can climb as they raise more cash leading to Phase 2. Then positive Phase 2 results provide huge value creation. By the time it is in Phase 3 patient investors will have already made a fortune. Look at Alnylam and Arrowhead for how a company can increase the share price with capital raises. Great science always finds new investors once data confirms the approach has strong potential. Don't have to wait until FDA approval to get rich.
News 
Market Data 
Discover 
